WorksheetsPathophysiology Exam III - ENDOCRINE PANCREAS
Total questions: 61
Worksheet time: 33mins
Multicellular islets comprise only (1) of the total pancreas
(1) 10%
(1) 1%
(1) 0.1%
(1) 2%
(1) 0.01%
(1) are more highly vascularized than the (2)
(1) islets
(2) exocrine pancreatic tissues
(1) exocrine pancreatic tissues
(2) islets
T/F Only the parasympathetic axons enter the islets and either directly contact cells or terminate in the interstitial space between the cells
True
False
Islets are formed by the following types of cells
Insulin-secreting beta cells
Glucagon-secreting alpha cells
Somatostatin-secreting delta cells
Pancreatic polypeptide [PP] secreting cell
Secrete hormones that counter the effects of insulin
Insulin-secreting beta cells
Glucagon-secreting alpha cells
Somatostatin-secreting delta cells
Pancreatic polypeptide [PP] secreting cell
60% of the cells
Insulin-secreting beta cells
Glucagon-secreting alpha cells
Somatostatin-secreting delta cells
Pancreatic polypeptide [PP] secreting cell
30% of the cells
Insulin-secreting beta cells
Glucagon-secreting alpha cells
Somatostatin-secreting delta cells
Pancreatic polypeptide [PP] secreting cell
30% of the cells
Insulin-secreting beta cells
Glucagon-secreting alpha cells
Somatostatin-secreting delta cells
Pancreatic polypeptide [PP] secreting cell
<1% of the cells
Insulin-secreting beta cells
Glucagon-secreting alpha cells
Somatostatin-secreting delta cells
Pancreatic polypeptide [PP] secreting cell
T/F the endocrine pancreas is composed of islets of langerhans that are distributed throughout the exocrine pancreas
True
False
What is the circulatory half-life of insulin?
3-5 minutes
3-5 hours
5-10 hours
5-10 minutes
30 minutes
Insulin is catabolized by the
Liver
Pancreas
Kidney
Thyroid
Stomach
What percentage of insulin is catabolized on its first pass through the liver?
20%
10%
50%
30%
5%
Insulin is secreted from (1) to the (2)
(1) portal vein
(2) pancreas
(1) pancreas
(2) portal vein
(1) liver
(2) kidney
(1) liver
(2) portal vein
(1) kidney
(2) portal vein
T/F recombinant insulin is used clinically to treat diabetes insipidus
True
False
T/F glucose is the primary physiologic stimulant of insulin release
True
False
Binding to insulin receptors present
Inside of target cells
On the surfaces of target cells
Surrounding the target cells
In muscle and liver cells only
In muscle, liver, and fat cells
Insulin receptor is composed of (1) linked by disulfide bonds
(1) two alpha and two beta subunits
(1) one alpha and one beta subunits
(1) two alpha and one beta subunits
(1) one alpha and two beta subunits
T/F binding of insulin to the extracellular beta subunits activate a tyrosine kinase present in the cytoplasmic domain of the alpha subunit, resulting in autophosphorylation of the alpha subunit
True
False
T/F receptor kinase activation is the critical first step in a cascade of intracellular events that begins with the phosphorylation of the insulin receptor substrates
True
False
Insulin promotes fuel storage by stimulating glycogen synthesis and storage in the
Pancreas
Liver
Kidney
Stomach
Small intestine
Insulin inhibits hepatic glucose output by inhibiting (1)
Gluconeogenesis
Glycogenolysis
Both
Neither
Gluconeogenesis
Glucose synthesis
Glucose breakdown
Glycogenolysis
Glycogen synthesis
Glycogen breakdown
T/F insulin inhibits the formation of precursors for fatty acid synthesis
True
False
Which of the following is true of insulin?
Stimulates lipogenesis
Inhibits fatty acid oxidation and the production of ketone antibodies
Inhibits lipogenesis
Stimulates fatty acid oxidation and the production of ketone antibodies
T/F diabetes mellitus is the presence of hyperglycemia
True
False
Diagnostic criteria for diabetes includes fasting plasma glucose of ≥
120 mg/dL
125 mg/dL
226 mg/dL
126 mg/dL
124 mg/dL
Diagnostic criteria for diabetes includes random plasma glucose of ≥ (1) for classic symptoms of hyperglycemia
100 mg/dL
200 mg/dL
226 mg/dL
126 mg/dL
127 mg/dL
What is the oral glucose tolerance test [OGTT]?
a 4-hour plasma glucose level ≥ 200 mg/dL following a standard 85g oral glucose load
a 4-hour plasma glucose level ≥ 100 mg/dL following a standard 75g oral glucose load
a 2-hour plasma glucose level ≥ 200 mg/dL following a standard 75g oral glucose load
a 2-hour plasma glucose level ≥ 100 mg/dL following a standard 75g oral glucose load
Advantages of using A1C for screening
No need to fast
A reflection of glucose over time
High sensitivity
High specificity
Disadvantages of using A1C for screening
Low sensitivity
Low specificity
Fasting required
Unable to show glucose reflection over time
Beta cell destruction, usually leading to absolute insulin defficiency
Type I diabetes mellitus
Type II diabetes mellitus
Gestational diabetes mellitus [GDM]
Examples include autoimmune and idiopathic
Type I diabetes mellitus
Type II diabetes mellitus
Gestational diabetes mellitus [GDM]
Ranges from predominantly insulin resistant with relative insulin deficiency to a predominant secretory defect with insulin resistance
Type I diabetes mellitus
Type II diabetes mellitus
Gestational diabetes mellitus [GDM]
Degree of glucose intolerance occurring or first being recognized during pregnancy, a time when insulin resistance and beta cell hyperplasia occurs normally
Type I diabetes mellitus
Type II diabetes mellitus
Gestational diabetes mellitus [GDM]
Women diagnosed with GDM have a high risk for later developing
Type I diabetes mellitus
Type II diabetes mellitus
Maturity-onset diabetes of the young [MODY]
Drug-induced diabetes mellitus
TF maturity-onset diabetes for the young [MODY] is defined as autosomal dominant mutations of multiple genes
True
False
Genetic defects in insulin action
Type A insulin resistance
Pancreatitis
Cystic fibrosis
Acromegaly
Cushing syndrome
Diseases of the exocrine pancreas
Type A insulin resistance
Pancreatitis
Cystic fibrosis
Acromegaly
Cushing syndrome
Diseases of the endocrine
Pheochromocytoma
Pancreatitis
Cystic fibrosis
Acromegaly
Cushing syndrome
Drug-induced diabetes mellitus
Alpha-interferon
Beta-adrenergic agonists
Diazoxide
Glucorticoids
Nicotinic acid
Somatostatin cells inhibit
Insulin
Glucagon
Both insulin and glucagon
None; it stimulates insulin and glucagon
Insulin cells inhibit
Insulin
Glucagon
Both somatostatin and glucagon
None; it stimulates somatostatin and glucagon
Glucagon cells inhibit
Insulin
Glucagon
Both insulin and somatostatin
None; it stimulates insulin and somatostatin
A chain in insulin
From 1-21
From 1-30
B chain in insulin
From 1-21
From 1-30
If the C-peptide is present, then it is
Insulin
Proinsulin
How do you form insulin?
Cleaving the C-peptide, leaving A chain and B chain
Cleaving the A chain, leaving C-peptide and B chain
Cleaving B chain, leaving C-peptide and A chain
What allows the glucose to enter the beta cell?
Glucokinase
GLUT
GLP-1
ATP
What enhances the regulation of insulin secretion once glucose has entered the cell?
Glucokinase
GLUT
GLP-1
ATP
What is the important product of glycolysis that induces the insulin secretion?
Glucokinase
GLUT
GLP-1
ATP
Pyruvate
The (1) channel is closed during depolarization, while the (2) channel is opened
(1) K+
(2) Ca+
(1) Ca+
(2) K+
Both are incorrect; they both are opened
Both are incorrect; they both are closed
Secondary messenger during the regulation of insulin secretion
K+ channel
Ca+ channel
T/F loss-of-function mutations in GLUT that impair insulin release can lead to early onset of mild diabetes
True
False
Diagnosed in childhood
DM1
DM2
Diagnosed in adulthood
DM1
DM2
Absolute deficiency
DM1
DM2
Impaired secretion
DM1
DM2
DM1
Insulin resistance
No insulin resistance
Obesity
Obesity is not a factor
Autoimmune disease
DM2
Insulin resistance
No insulin resistance
Obesity
Obesity is not a factor
Autoimmune disease
